These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 26281083)

  • 1. [STATINS FOR THE PREVENTION OF CARDIOVASCULAR DISEASE AND DIABETES INCIDENCE--THE BENEFITS VERSUS THE RISKS].
    Lavie G; Cohen S
    Harefuah; 2015 Jun; 154(6):382-6, 404. PubMed ID: 26281083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy and related risk of new-onset type 2 diabetes mellitus.
    Ruscica M; Macchi C; Morlotti B; Sirtori CR; Magni P
    Eur J Intern Med; 2014 Jun; 25(5):401-6. PubMed ID: 24685426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin-associated incident diabetes: a literature review.
    Park ZH; Juska A; Dyakov D; Patel RV
    Consult Pharm; 2014; 29(5):317-34. PubMed ID: 24849689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Appropriate clinical use of statins: a discussion of the evidence, scope, benefits, and risk.
    Perlmutter D; Golomb B; Sinatra S; Campbell AW
    Altern Ther Health Med; 2013; 19 Suppl 1():14-25. PubMed ID: 23981463
    [No Abstract]   [Full Text] [Related]  

  • 5. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S; Ridker PM
    Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks.
    Minder CM; Blumenthal RS; Blaha MJ
    Curr Opin Cardiol; 2013 Sep; 28(5):554-60. PubMed ID: 23928920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing Primary Prevention and Statin-Induced Diabetes Mellitus Prevention.
    Rochlani Y; Kattoor AJ; Pothineni NV; Palagiri RDR; Romeo F; Mehta JL
    Am J Cardiol; 2017 Oct; 120(7):1122-1128. PubMed ID: 28797470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
    Bruckert E; Ferrières J
    Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statins with a perspective of lifelong therapy].
    Ertaş FS
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and the risk of incident diabetes mellitus: a review of the literature.
    Colbert JD; Stone JA
    Can J Cardiol; 2012; 28(5):581-9. PubMed ID: 22658337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin therapy and risk of diabetes in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas J; Liontou C; Chrysohoou C; Masoura C; Aznaouridis K; Pitsavos C; Stefanadis C
    Atherosclerosis; 2014 Nov; 237(1):140-5. PubMed ID: 25238223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and New-Onset Diabetes in Cardiovascular and Kidney Disease Cohorts: A Meta-Analysis.
    Kamran H; Kupferstein E; Sharma N; Karam JG; Myers AK; Youssef I; Sowers JR; Gustafson DR; Salifu MO; McFarlane SI
    Cardiorenal Med; 2018; 8(2):105-112. PubMed ID: 29617000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prevention of cardiovascular events in patients with major mental illness: a possible role for statins.
    Andrade C
    Bipolar Disord; 2013 Dec; 15(8):813-23. PubMed ID: 24119211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins: have we found the Holy Grail?
    Jeger R; Dieterle T
    Swiss Med Wkly; 2012; 142():w13515. PubMed ID: 22315166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is statin-induced diabetes clinically relevant? A comprehensive review of the literature.
    Bell DS; DiNicolantonio JJ; O'Keefe JH
    Diabetes Obes Metab; 2014 Aug; 16(8):689-94. PubMed ID: 24373206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and the elderly: recent evidence and current indications.
    Schiattarella GG; Perrino C; Magliulo F; Ilardi F; Serino F; Trimarco V; Izzo R; Amato B; Terranova C; Cardin F; Militello C; Leosco D; Trimarco B; Esposito G
    Aging Clin Exp Res; 2012 Jun; 24(3 Suppl):47-55. PubMed ID: 23160507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy?
    Navarese EP; Szczesniak A; Kolodziejczak M; Gorny B; Kubica J; Suryapranata H
    Am J Cardiovasc Drugs; 2014 Apr; 14(2):79-87. PubMed ID: 24174174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the impact of the recent controversy over statins in France: the EVANS study.
    Saib A; Sabbah L; Perdrix L; Blanchard D; Danchin N; Puymirat E
    Arch Cardiovasc Dis; 2013 Oct; 106(10):511-6. PubMed ID: 24080324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized Statin Benefit for Determining Statin Eligibility in the Primary Prevention of Cardiovascular Disease.
    Thanassoulis G; Williams K; Altobelli KK; Pencina MJ; Cannon CP; Sniderman AD
    Circulation; 2016 Apr; 133(16):1574-81. PubMed ID: 26945047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.